Stay updated on Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s site revision indicator changed from v3.7.2 to v3.8.0; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-31T13:29:13.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide NIH announcement says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.7%
    Check dated 2026-10-24T16:54:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T16:38:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T16:53:55.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The revision label on the Record History page updated from v3.6.6 to v3.7.0, signaling a new version of the page. This is a metadata update and does not modify the study data or its history.
    Difference
    0.1%
    Check dated 2026-09-19T19:32:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The history log now shows a new revision v3.6.6 added and the previous v3.6.5 removed, indicating a version update to the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:36:12.000Z thumbnail image

Stay in the know with updates to Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib After First-line TKI Failure in ROS1 NSCLC Clinical Trial page.